| Primary |
| Product Used For Unknown Indication |
39.0% |
| Psoriasis |
9.3% |
| Rash |
8.5% |
| Pyelonephritis |
5.9% |
| Migraine |
5.1% |
| Drug Use For Unknown Indication |
4.2% |
| Hypertriglyceridaemia |
3.4% |
| Intertrigo |
3.4% |
| Asthenia |
2.5% |
| Contraception |
2.5% |
| Eczema |
2.5% |
| Erysipelas |
2.5% |
| Arthropod Bite |
1.7% |
| Diabetes Mellitus |
1.7% |
| Inflammation |
1.7% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.7% |
| Vasculitis |
1.7% |
| Angiosarcoma |
0.8% |
| Ankylosing Spondylitis |
0.8% |
| Asthma |
0.8% |
|
| Diabetes Mellitus |
9.7% |
| Erysipelas |
9.7% |
| Myalgia |
9.7% |
| Vasculitis |
9.7% |
| Drug Ineffective |
6.5% |
| Pruritus |
6.5% |
| Pustular Psoriasis |
6.5% |
| Adrenal Insufficiency |
3.2% |
| Asthenia |
3.2% |
| Cataract |
3.2% |
| Cerebral Thrombosis |
3.2% |
| Cheilitis |
3.2% |
| Diabetic Ketoacidosis |
3.2% |
| Foetal Exposure During Pregnancy |
3.2% |
| Headache |
3.2% |
| Hypersensitivity |
3.2% |
| Medication Error |
3.2% |
| Myoglobin Blood Increased |
3.2% |
| Necrotising Fasciitis |
3.2% |
| Ocular Hyperaemia |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
42.6% |
| Psoriasis |
12.2% |
| Drug Use For Unknown Indication |
7.0% |
| Hypertension |
4.3% |
| Mycosis Fungoides |
4.3% |
| T-cell Lymphoma |
3.5% |
| Dyslipidaemia |
2.6% |
| Hepatitis C |
2.6% |
| Sigmoiditis |
2.6% |
| Antioxidant Therapy |
1.7% |
| Back Pain |
1.7% |
| Bronchopneumopathy |
1.7% |
| Contraception |
1.7% |
| Diabetes Mellitus |
1.7% |
| Inflammation |
1.7% |
| Migraine |
1.7% |
| Pneumonia |
1.7% |
| Prophylaxis |
1.7% |
| Tachycardia |
1.7% |
| Ankylosing Spondylitis |
0.9% |
|
| Osteonecrosis |
13.3% |
| Diabetes Mellitus |
6.7% |
| Drug Ineffective |
6.7% |
| Lymphopenia |
6.7% |
| Pancreatitis |
6.7% |
| Pancreatitis Acute |
6.7% |
| Squamous Cell Carcinoma |
6.7% |
| Vasculitis |
6.7% |
| Aggression |
3.3% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Lipodystrophy Acquired |
3.3% |
| Necrotising Fasciitis |
3.3% |
| Product Label Confusion |
3.3% |
| Psoriasis |
3.3% |
| Rash |
3.3% |
| Renal Failure Acute |
3.3% |
| Skin Plaque |
3.3% |
| Streptococcal Bacteraemia |
3.3% |
| Tracheobronchitis |
3.3% |
| Urticaria |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Rash |
16.0% |
| Drug Use For Unknown Indication |
13.6% |
| Hepatitis C |
6.4% |
| Hypertension |
4.3% |
| Crohn's Disease |
4.0% |
| Psoriatic Arthropathy |
3.9% |
| Constipation |
3.4% |
| Prophylaxis |
3.4% |
| Psoriasis |
3.4% |
| Hiv Infection |
3.3% |
| Pain |
3.3% |
| Nutritional Support |
3.0% |
| Chronic Myeloid Leukaemia |
2.5% |
| Fluid Retention |
2.4% |
| Lung Adenocarcinoma |
2.4% |
| Rheumatoid Arthritis |
2.2% |
| Pruritus |
1.9% |
| Anxiety |
1.8% |
| Chest Pain |
1.8% |
|
| Rash Maculo-papular |
9.8% |
| Thrombocytopenia |
9.8% |
| Osteonecrosis |
6.5% |
| Pancytopenia |
6.5% |
| Toxic Skin Eruption |
6.5% |
| Weight Increased |
6.5% |
| Vomiting |
5.4% |
| Xerosis |
5.4% |
| Electrocardiogram T Wave Amplitude Decreased |
4.3% |
| Hyperthyroidism |
4.3% |
| Skin Exfoliation |
4.3% |
| Tremor |
4.3% |
| Anal Abscess |
3.3% |
| Bartholin's Abscess |
3.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.3% |
| Positron Emission Tomogram Abnormal |
3.3% |
| Pruritus |
3.3% |
| Psoriasis |
3.3% |
| Rash |
3.3% |
| Renal Failure |
3.3% |
|
